Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS). [PDF]
Stepien KM +14 more
europepmc +1 more source
Commission des Communautes Europeennes: Groupe du Porte-Parole. Rendez-vous de midi du 29.3.1988 (C.D. Ehlermann) = Commission of European Communities: Spokesman Group. Appointment at Noon on 29.3.1988 (C.D. Ehlermann). Press Spokesman Service Note to National Offices Bio No. (88) 112, 29 March 1988 [PDF]
core
Mucopolysaccharidoses-What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview. [PDF]
Lipiński P +11 more
europepmc +1 more source
Nonviral delivery of nCas9 for "safe harbor" integration to treat MPS IVA. [PDF]
Ou L.
europepmc +1 more source
Real-world treatment with elosulfase alfa in patients with MPS IVA is associated with improved endurance over time. [PDF]
Burton BK +6 more
europepmc +1 more source
Identification of Surrogate Biomarkers for Mucopolysaccharidosis Type IVA. [PDF]
Ago Y +4 more
europepmc +1 more source
The effects of decomposing animal remains on cave invertebrate communities [PDF]
MacDonald, J, Terrell-Nield, C
core
KBG syndrome: report and follow-up on three unrelated patients observed at different ages. [PDF]
Serra G +9 more
europepmc +1 more source
The National Economic Accounts of the United States: Review, Appraisal, and Recommendations [PDF]
National Accounts Review Committee
core

